Vanguard S&P Mid-Cap 400 ETF

Invests in stocks in the S&P MidCap 400 Index, representing 400 medium-size U.S. companies.Focuses on closely tracking the index’s return, which is considered a gauge of overall U.S. mid-cap stock returns.Offers high potential for investment growth; share value rises and falls more sharply than that of funds holding bonds.More appropriate for long-term goals where your money’s growth is essential.On March 14, 2023, this ETF underwent a 2:1 share split, which decreased the price per share of the ETF with a proportionate increase in the number of shares outstanding. Historical share price data has not been adjusted for the split except where market data is being used, as indicated. Although certain data may reflect both pre-and post-split prices, returns are not impacted.

Vanguard S&P Mid-Cap 400 ETF trades as IVOO on AMEX. The company is classified in Financial Services / Asset Management - Global and reports in USD.

The current profile places the business in Asset Management - Global. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Vanguard S&P Mid-Cap 400 ETF can be compared against peers such as BNY Mellon US Large Cap Core Equity ETF, Dimensional - International High Profitability ETF, iShares MSCI Emerging Markets Min Vol Factor ETF, Goldman Sachs ActiveBeta International Equity ETF, Putnam Focused Large Cap Value ETF, Vanguard Materials ETF.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $5.60B, beta of 1.05, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

IVOO currently shows total debt of N/A and beta of 1.05. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: N-MFP3 (2026-06-05 00:00:00), 497 (2026-05-20 00:00:00), N-MFP3 (2026-05-07 00:00:00), N-CSRS (2026-04-29 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://investor.vanguard.com/investment-products/etfs/profile/ivoo

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.